#315 of 500 · Trade, Professional & Labor

Pharmaceutical Research And Manufacturers Of America

EIN 53-0241211 · DC · NTEE n/a · Form 990, fiscal 2023

A Washington, D.C.-based trade association founded in 1958 that represents the country's leading biopharmaceutical research and biotechnology companies. It advocates for public policies supporting pharmaceutical innovation and patient access to medicines, including intellectual-property protections and market-based pricing, and conducts research, communications, and lobbying at the federal, state, and international levels on behalf of its member companies.

Financials, fiscal 2023

Revenue

$483.0M

Expenses

$426.5M

Total assets

$399.0M

Net assets

$210.9M

Operating margin

11.7%

1-year growth

-15.0%

5-year growth (CAGR)

-2.1%

Reserve (years of spending)

5.9

Contributions share

0.1%

Programme spending

96.8%

Fundraising cost

n/a

Executive pay share

5.03%

Employees

295

Revenue per employee

$1.6M

Grants paid

$32.5M

Years filing

64

NFP Health Score: 75 / 100

Financial 68 · Governance 75 · Operational 90. The score is built from Form 990 line items only. It cannot measure how well an organisation delivers its mission.

Mission

To conduct effective advocacy for public policies that encourage the discovery of important, new medicines for patients by biopharmaceutical research companies.

Revenue history